Anthropic has introduced a new ai tool, called Claude Science, aimed at scientists and medical research and development. The tool is described as an ai workbench for scientists, and its launch is accompanied by anthropic's own internal drug discovery programs focused on neglected diseases. Reports also suggest that anthropic is entering the pharmaceutical sector, with some outlets noting the company's efforts to tackle diseases that big pharma considers unprofitable.